EVOMYO
LIVE

Serial Number

98040253

Owner

SAREPTA THERAPEUTICS, INC.

Attorney

Maury M. Tepper, III

Filing Date

Jun 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EVOMYO Trademark

Serial Number: 98040253

EVOMYO is a trademark filed by SAREPTA THERAPEUTICS, INC. on June 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

SAREPTA THERAPEUTICS, INC. (109 trademarks)

215 FIRST STREET, SUITE 7
CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

June 13, 2023

Registration Date

Not Registered

Published for Opposition

May 21, 2024

Goods & Services

Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs being pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jan 12, 2026 EX3G
SOU EXTENSION 3 FILED
Jan 12, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 12, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 10, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 9, 2025 EX2G
SOU EXTENSION 2 FILED
Jul 9, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 9, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 13, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 13, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 13, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 16, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 16, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 6, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 6, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 6, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 31, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2023 NWOS
NEW APPLICATION ENTERED
Jun 16, 2023 NWAP